The main clinical characteristics and laboratory parameters of patients and controls
| IBD | UC | CD | IBS | HC | |
|---|---|---|---|---|---|
| Patients | 143 | 83 | 60 | 32 | 50 |
| Gender F/M | 84/59 | 48/35 | 36/24 | 21/11 | 25/25 |
| Age | 40.2±11.7 | 39.9±11.5 | 40.6±12.4 | 41.3±12.8 | 40.3±11.8 |
| BMI, kg/m2 | 24.9±4 | 25.4±4.2 | 24.2±3.9 | 25.2±4.3 | 23.2±3.8 |
| Disease duration | 4 (1.0–10.0) | 4.0 (2.0–10.0) | 4 (0.25–11.5) | – | – |
| Serum ST2, pg/mL | 56.8 (41.9–87.2) | 54.2 (41.3–93.0) | 63.8 (42.7–88.4) | 39.9 (25.9–68.7) | 30.7 (20.2–54.3) |
| WCC, /mm3 | 7660±2493 | 7821±2682 | 7274±2285 | 6754±1873 | 6797±1539 |
| hs-CRP, mg/L | 6.21 (3.5–18.0) | 5.0 (3.5–12.0) | 8.8 (3.3–30.1) | 1.3 (1.08–3.3) | 4.9 (3.1–7.1) |
| ESR | 15.0 (9.0–30.0) | 12.0 (8.0–24.0) | 21.0 (11.0–43.3) | 4.5 (2.3–11.0) | 8.5 (2.8–13.0) |
| Ferritin, ng/mL | 34.7 (13.2–65.0) | 25.0 (8.75–55.0) | 42.6 (22.4–82.6) | 15.8 (5.2–30.2) | 21.2 (12.1–52.3) |
| Albumin, g/dL | 4.5 (4.0–4.7) | 4.5 (4.1–4.7) | 4.4 (4.0–4.7) | 4.6 (4.2–4.9) | 4.6 (4.3–4.8) |
| Platelet, ×103/mm3 | 274 (231–359) | 285 (232–362) | 265 (227–348) | 243 (213–299) | 250 (215–305) |
Values are presented using means±SDs for normally distributed data and medians and first and third quartiles in the brackets for the non-normally distributed variables.
BMI, body mass index; CD, Crohn's disease; ESR, erythrocyte sedimentation rate; F, female; HC, healthy controls; hs-CRP, high-sensitive C reactive protein; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; M, male; UC, ulcerative colitis; WCC, white cell count.